COSCIENS Biopharma Inc. Increase Decrease In Net Assets Available For Benefits
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease In Net Assets Available For Benefits of $87.00 thousand for the 9-month period ending 2024-09-30, per its 6-K filed 2024-11-12.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInNetAssetsAvailableForBenefits · last filed 2024-11-12
- COSCIENS Biopharma Inc. increase decrease in net assets available for benefits for the quarter ending 2024-09-30 was $66.00K.
- COSCIENS Biopharma Inc. increase decrease in net assets available for benefits for the quarter ending 2023-06-30 was $65.00K, a 0.00% change year-over-year.
- COSCIENS Biopharma Inc. increase decrease in net assets available for benefits for the quarter ending 2023-03-31 was $71.00K, a 24.56% increase year-over-year.
- COSCIENS Biopharma Inc. increase decrease in net assets available for benefits for the quarter ending 2022-12-31 was $65.00K.
| Period end | Increase Decrease In Net Assets Available For Benefits 3 month | Increase Decrease In Net Assets Available For Benefits 6 month | Increase Decrease In Net Assets Available For Benefits 9 month | Increase Decrease In Net Assets Available For Benefits 12 month |
|---|---|---|---|---|
| 2024-09-30 | $66.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $87.00K 6-K · filed 2024-11-12 | ||
| 2024-06-30 | $21.00K 6-K · filed 2024-08-13 | |||
| 2023-12-31 | $266.00K 20-F/A · filed 2024-07-17 | |||
| 2023-06-30 | $65.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-09 | $136.00K 6-K · filed 2023-08-09 | $201.00K derived: sum of 3 quarters · filed 2024-07-17 | $261.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-03-31 | $71.00K 6-K · filed 2023-05-09 | $136.00K derived: sum of 2 quarters · filed 2024-07-17 | $196.00K derived: sum of 3 quarters · filed 2024-07-17 | $261.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2022-12-31 | $65.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $125.00K derived: sum of 2 quarters · filed 2024-07-17 | $190.00K derived: sum of 3 quarters · filed 2024-07-17 | $247.00K 20-F/A · filed 2024-07-17 |
| 2022-09-30 | $60.00K derived: 6-K 9 month − 6-K/A 6 month · filed 2022-11-03 | $125.00K derived: sum of 2 quarters · filed 2022-11-03 | $182.00K 6-K · filed 2022-11-03 | |
| 2022-06-30 | $65.00K derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | $122.00K 6-K/A · filed 2022-08-04 | ||
| 2022-03-31 | $57.00K 6-K · filed 2022-05-11 |